Avanos Medical, Inc.
AVNSNYSEHealthcare● Active
$25.05
+$0.05(+0.20%)
Market Cap$1.2B
P/E Ratio—
52W High$25.49
52W Low$9.303
Avanos Medical, Inc. (AVNS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVNS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.70B | $0.69B | $0.67B | $0.68B | $0.74B |
| Cost of Revenue | $0.35B | $0.31B | $0.29B | $0.29B | $0.36B |
| Gross Profit | $0.35B | $0.38B | $0.38B | $0.39B | $0.38B |
| Gross Margin %(computed) | 49.77% | 55.44% | 56.39% | 57.62% | 51.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.03B | $0.03B | $0.03B | $0.03B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.41B | $0.34B | $0.31B | $0.35B | $0.29B |
| Operating Income | ($0.06B) | $0.04B | $0.07B | $0.04B | $0.09B |
| Operating Margin %(computed) | -8.78% | 5.82% | 9.65% | 6.12% | 11.66% |
| Interest Income | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | ($0.07B) | ($0.40B) | ($0.01B) | $0.03B | $0.01B |
| Income Tax Expense | $0.00B | ($0.02B) | $0.00B | $0.01B | $0.00B |
| Net Income | ($0.07B) | ($0.39B) | ($0.06B) | $0.05B | $0.01B |
| Net Margin %(computed) | -9.68% | -57.01% | -9.18% | 7.38% | 0.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.46 | $-8.53 | $-1.33 | $1.08 | $0.13 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.03B) | ($0.35B) | $0.05B | $0.08B | $0.05B |
| EBITDA Margin %(computed) | -4.73% | -50.25% | 7.52% | 11.37% | 6.57% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Avanos Medical, Inc. data
About Avanos Medical, Inc. (AVNS) Income Statement
Avanos Medical, Inc. (AVNS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AVNS reported revenue of $0.70B, gross profit of $0.35B (gross margin 49.77%), and net income of ($0.07B) — a net profit margin of -9.68%.
Frequently asked questions
AVNS · 4 questionsAvanos Medical, Inc. (AVNS) reported revenue of $0.70B for 2025, up 1.9% year-over-year.
AVNS revenueAVNS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08